Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Sections
    • Collections
  • Podcasts
  • Author Info
    • Overview for authors
    • Publication fees
    • Forms
    • Editorial policies
    • Submit a manuscript
    • Open access
  • Careers
  • Alerts
    • Email alerts
    • RSS
  • About
    • General information
    • Staff
    • Editorial Board
    • Contact
  • CMAJ JOURNALS
    • CMAJ
    • CMAJ Open
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CJS
  • CMAJ JOURNALS
    • CMAJ
    • CMAJ Open
    • JAMC
    • JPN
CJS

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Sections
    • Collections
  • Podcasts
  • Author Info
    • Overview for authors
    • Publication fees
    • Forms
    • Editorial policies
    • Submit a manuscript
    • Open access
  • Careers
  • Alerts
    • Email alerts
    • RSS
  • About
    • General information
    • Staff
    • Editorial Board
    • Contact
  • Subscribe to our alerts
  • RSS feeds
  • Follow CJS on Twitter
Research

The effect of aerosolized indomethacin on lung inflammation and injury in a rat model of blunt chest trauma

Raymond L. Kao, Weixiong Huang, Claudio M. Martin and Tao Rui
Can J Surg December 01, 2018 61 (6 Suppl 1) S208-S218; DOI: https://doi.org/10.1503/cjs.014318
Raymond L. Kao
From the Department of National Defense, Royal Canadian Medical Services, Ottawa, Ont. (Kao); Critical Care Western, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ont. (Kao, Martin, Rui); and the Centre for Critical Illness Research, Lawson Health Research Institute, London, Ont. (Kao, Martin, Rui)
MD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Weixiong Huang
From the Department of National Defense, Royal Canadian Medical Services, Ottawa, Ont. (Kao); Critical Care Western, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ont. (Kao, Martin, Rui); and the Centre for Critical Illness Research, Lawson Health Research Institute, London, Ont. (Kao, Martin, Rui)
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudio M. Martin
From the Department of National Defense, Royal Canadian Medical Services, Ottawa, Ont. (Kao); Critical Care Western, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ont. (Kao, Martin, Rui); and the Centre for Critical Illness Research, Lawson Health Research Institute, London, Ont. (Kao, Martin, Rui)
MD, MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tao Rui
From the Department of National Defense, Royal Canadian Medical Services, Ottawa, Ont. (Kao); Critical Care Western, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, Ont. (Kao, Martin, Rui); and the Centre for Critical Illness Research, Lawson Health Research Institute, London, Ont. (Kao, Martin, Rui)
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Responses
  • Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • Tables
  • Fig. 1
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1

    Total protein levels in bronchoalveolar lavage fluid (BALF) at 3 hours post–blunt chest trauma after isolated pulmonary contusion injury with chest impact energy levels of 0.5 J, 0.75 J, and 1.0 J. Values are means ± standard deviations for n = 8 rats.

  • Fig. 2
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2

    The percentage of polymorphonuclear leukocyte (PMN) in bronchoalveolar lavage fluid (PMN numbers ÷ total numbers of leukocytes at 3 hours post–blunt chest trauma after isolated pulmonary contusion with chest impact energies of 0.5 J, 0.75 J, and 1.0 J. Values are means ± standard deviations for n = 8 rats.

  • Fig. 3
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3

    Mean arterial pressure (MAP) and heart rate (HR) reading at 3 hours post–blunt chest trauma (BCT) for the 4 rat groups. Sham, BCT, BCT + saline, and BCT + indomethacin groups were subjected to a blunt energy impact of 0.75 J. All physiological variables were recorded for 180 minutes following BCT. Values are means ± standard deviations for n = 8 rats.

  • Fig. 4
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4

    Arterial blood gas measurements: pH, PaCO2 and PaO2 for the 4 rat groups. Sham, BCT (blunt chest trauma), BCT + saline, and BCT + indomethacin groups were subjected to a blunt energy impact of 0.75 J. (A) pH at 15 and 180 minutes post-BCT. (B) PaCO2 at 15 and 180 minutes post-BCT. (C) PaO2 at 15 and 180 minutes post-BCT. Values are means ± standard deviations for n = 8 rats.

  • Fig. 5
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 5

    Interstitial lung permeability: bronchoalveolar lavage fluid (BALF) alveolar protein concentration and FD-70 at 3 hours post–blunt chest trauma (BCT) for the 4 rat groups. Sham, BCT, BCT + saline, and BCT + indomethacin groups were subjected to a blunt energy impact of 0.75 J. Both (A) alveolar protein concentration and (B) FD-70 levels in BALF were significantly reduced with administration of indomethacin. Values are means ± standard deviations for n = 8 rats.

  • Fig. 6
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 6

    (A) Bronchoalveolar lavage fluid (BALF) pulmonary white blood cell count and (B) polymorphonuclear leukocytes (PMN) percentage at 3 hours post–blunt chest trauma (BCT) for the 4 rat groups. Sham, BCT, BCT + saline, and BCT + indomethacin groups were subjected to a blunt energy impact of 0.75 J. There were significant increases in the PMN percentage, but not in the total white blood cell count. The BCT-induced increase in PMNs was reduced significantly by indomethacin administration compared with the sham and BCT groups. Values are means ± standard deviations for n = 8 rats.

  • Fig. 7
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 7

    Bronchoalveolar lavage fluid (BALF) (A) tumour necrosis factor (TNF)-α and (B) interleukin (IL)-6 at 3 hours post–blunt chest trauma (BCT). Sham, BCT, BCT + saline, and BCT + indomethacin groups were subjected to a blunt energy impact of 0.75 J. The TNF-α and IL-6 concentrations were measured using ELISA. Values are means ± standard deviations.

  • Fig. 8
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 8

    Pulmonary histopathology using hematoxylin and eosin stain (magnification ×100). We found infiltration of inflammatory cells, intra-alveolar hemorrhage, high levels of intra-alveolar exudates and interstitial edema in the blunt groups. The indomethacin-treated group showed a comparatively milder inflammatory cellular infiltrate and intra-alveolar hemorrhage. (A) Normal rat lung histology. (B) Histopathology of a rat with blunt chest trauma (BCT). (C) Histopathology of a rat with BCT + saline. (D) Histopathology of a rat with BCT + indomethacin.

Tables

  • Figures
    • View popup
    Table 1

    Impact energy assessment for optimal pulmonary injuries — macro examination of right lung injuries

    Impact energyRight lung injuries, no.Left lung injuries, no.Right lung injuries grading ± SEMDeaths, no.
    Sham001.00 ± 0.000
    0.5 J502.13 ± 0.350
    0.75 J803.50 ± 0.420
    1.0 J1013.88 ± 0.402
    • SEM = standard error of the mean.

PreviousNext
Back to top

In this issue

Canadian Journal of Surgery: 61 (6 Suppl 1)
Can J Surg
Vol. 61, Issue 6 Suppl 1
1 Dec 2018
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CJS.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The effect of aerosolized indomethacin on lung inflammation and injury in a rat model of blunt chest trauma
(Your Name) has sent you a message from CJS
(Your Name) thought you would like to see the CJS web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The effect of aerosolized indomethacin on lung inflammation and injury in a rat model of blunt chest trauma
Raymond L. Kao, Weixiong Huang, Claudio M. Martin, Tao Rui
Can J Surg Dec 2018, 61 (6 Suppl 1) S208-S218; DOI: 10.1503/cjs.014318

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
The effect of aerosolized indomethacin on lung inflammation and injury in a rat model of blunt chest trauma
Raymond L. Kao, Weixiong Huang, Claudio M. Martin, Tao Rui
Can J Surg Dec 2018, 61 (6 Suppl 1) S208-S218; DOI: 10.1503/cjs.014318
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

Similar Articles

Content

  • Current issue
  • Past issues
  • Collections
  • Alerts
  • RSS

Authors & Reviewers

  • Overview for Authors
  • Publication Fees
  • Forms
  • Editorial Policies
  • Submit a manuscript

About

  • General Information
  • Staff
  • Editorial Board
  • Contact Us
  • Advertising
  • Reprints
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. Print ISSN 0008-428X; Online ISSN 1488-2310.

All editorial matter in CJS represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected].

CMA Civility, Accessibility, Privacy

 

 

Powered by HighWire